Market Overview

Hilliard Lyons Maintains Long-term Buy on Pfizer, Inc., Raises PT to $32.00

Share:

Latest Ratings for PFE

DateFirmActionFromTo
Dec 2016GuggenheimInitiates Coverage OnNeutral
Nov 2016BarclaysUpgradesEqual-WeightOverweight
Nov 2016ArgusDowngradesBuyHold

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (PFE)